| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $311.1M | +77.8% |
| SG&A Expense | $116.4M | +18.9% |
| Operating Income | -$451.0M | -27.3% |
| Interest Expense | $7.2M | -76.0% |
| Pre-tax Income | -$552.0M | -6.9% |
| Income Tax | $61K | -74.6% |
| Net Income | -$552.1M | -6.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.0M | -96.6% |
| Current Assets | $66.4M | -89.1% |
| Total Assets | $510.3M | -43.8% |
| Current Liabilities | $267.5M | -9.0% |
| Total Liabilities | $327.5M | -3.6% |
| Stockholders' Equity | $182.8M | -67.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$383.1M | -12.7% |
| Capital Expenditures | $123.2M | +28.8% |
| Investing Cash Flow | -$123.2M | -28.8% |
| Financing Cash Flow | -$6.7M | -100.7% |
| Free Cash Flow | -$506.3M | -16.3% |